Truly phenomenal meeting. Great talks and panels. Hard questions. Exciting new ideas and directions. Thank you to the Levine-Riggs Diabetes Research Symposium for bringing us all together and helping drive progress in the field! #immunologymatters#changingwhatspossible#endt1d
Delighted to speak at the Rachmiel Levine-Arthur Riggs Diabetes Research Symposium! Bracing myself for an avalanche of knowledge! #immunologymatters#endt1d
I got my first R01! $3M dollars. 5 y. NIAID. Huge thank you to my co-investigators Holger Russ & Michael Brehm, my lab members & the foundations who believed in me, the Medical University of South Carolina & Hollings Cancer Center for an outstanding environment.#immunologymatters
The Food and Drug Administration is a critical partner in accelerating cures and therapies for type 1 diabetes. The nominee to run FDA knows first-hand how important that is. Dr. Heidi Overton, nominee to be the next FDA Commissioner, has shared with us that she lives with type 1 diabetes.
Incredibly proud of @leeanadenise1, a new K99/R00 recipient, for leading this work. JCI - Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes https://t.co/Q631AMh5VF
Happy to share a recent publication with our collaborators at Wilmer on crystalline drug delivery to the eye to treat wet age-related macular degeneration @JCRnEDITORS!
https://t.co/dgtOCkdCcp
& Recent press release:
https://t.co/FUwhMSRQae
@JHUBME@TTECJHU@HopkinsMedicine
Two interdisciplinary teams of UMass Chan faculty were awarded $45,000 each from the Dan and Diane Riccio Fund for Neuroscience to support their groundbreaking research in neuroscience: https://t.co/1EKCM2WuPT
#AdvancingTogether#neuroscience@summerbthyme@UMassChanGiving@UMass
Can mRNA vaccination induce tolerance rather than immunity? 🧬 Autoantigen mRNA-LNPs reduced disease in mouse models of MS and type 1 diabetes. A modular platform—but durability and safety remain preclinical.
https://t.co/mEFEhWzwZi
#Autoimmunity#Tregs
MD/PhD student Melanie Barbini has received an @NIH award that could have implications for multiple sclerosis and Alzheimer’s patients. Read about why she credits mentors Dorothy Schafer, PhD, and Chancellor David McManus: https://t.co/jy7FALOzFn #StudentSpotlight@UMassMDPhD
Based on a new NOA recieved this month, we are looking for a postdoctoral fellow with solid foundation of molecular skills, creativity, and translational passion to help us develop innovative CARs for targeting discrete subsets of T cells. DM or email me if interested
We are recruiting a postdoc to work on an NIH funded project to determine the role of aging and oncogene-induced stromal senescence on prostate cancer initiation and therapy resistance. See job posting and recent publication below.
https://t.co/TBSZNslFjg
https://t.co/lRZ2qseXfm
Congratulations to Dr. Marcus Ruscetti of @UMassChan Medical School on receiving the prestigious 2026 Pershing Square Sohn Cancer Prize — which recognizes scientists who are accelerating cures for cancer through innovative research. #CancerResearch
🔗 https://t.co/hiPMdY5Shb
New @NIH support for #diabetes-relevant #research@UMassChan: Louis Messina, MD, has received a 5-year, $3 million grant to study how aging changes immune cells and impairs wound healing. More here: https://t.co/CwaoW9fjY5
UMass Chan Medical School +1